999 related articles for article (PubMed ID: 31734354)
1. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota.
Chen D; Jin D; Huang S; Wu J; Xu M; Liu T; Dong W; Liu X; Wang S; Zhong W; Liu Y; Jiang R; Piao M; Wang B; Cao H
Cancer Lett; 2020 Jan; 469():456-467. PubMed ID: 31734354
[TBL] [Abstract][Full Text] [Related]
2. Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood.
Dai X; Guo Z; Chen D; Li L; Song X; Liu T; Jin G; Li Y; Liu Y; Ajiguli A; Yang C; Wang B; Cao H
Gut Microbes; 2020 Jul; 11(4):1043-1063. PubMed ID: 32228300
[TBL] [Abstract][Full Text] [Related]
3. Remodeling gut microbiota by Clostridium butyricum (C.butyricum) attenuates intestinal injury in burned mice.
Zhang D; Zhu C; Fang Z; Zhang H; Yang J; Tao K; Hu D; Han J; Yang X
Burns; 2020 Sep; 46(6):1373-1380. PubMed ID: 32014349
[TBL] [Abstract][Full Text] [Related]
4. Effect of Clostridium butyricum on High-Fat Diet-Induced Intestinal Inflammation and Production of Short-Chain Fatty Acids.
Choi Y; Choi SI; Kim N; Nam RH; Jang JY; Na HY; Shin CM; Lee DH; Min H; Kim YR; Seok YJ
Dig Dis Sci; 2023 Jun; 68(6):2427-2440. PubMed ID: 36670324
[TBL] [Abstract][Full Text] [Related]
5. Clostridium butyricum inhibits epithelial-mesenchymal transition of intestinal carcinogenesis through downregulating METTL3.
Zhang K; Dong Y; Li M; Zhang W; Ding Y; Wang X; Chen D; Liu T; Wang B; Cao H; Zhong W
Cancer Sci; 2023 Aug; 114(8):3114-3127. PubMed ID: 37243376
[TBL] [Abstract][Full Text] [Related]
6. The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue.
Hagihara M; Yamashita R; Matsumoto A; Mori T; Kuroki Y; Kudo H; Oka K; Takahashi M; Nonogaki T; Yamagishi Y; Mikamo H
Anaerobe; 2018 Dec; 54():8-18. PubMed ID: 30076897
[TBL] [Abstract][Full Text] [Related]
7. Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice.
Jia L; Li D; Feng N; Shamoon M; Sun Z; Ding L; Zhang H; Chen W; Sun J; Chen YQ
Sci Rep; 2017 Aug; 7(1):7046. PubMed ID: 28765642
[TBL] [Abstract][Full Text] [Related]
8. The Butyrate-Producing Bacterium
Hayashi A; Nagao-Kitamoto H; Kitamoto S; Kim CH; Kamada N
J Immunol; 2021 Apr; 206(7):1576-1585. PubMed ID: 33597149
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota dynamics and fecal SCFAs after colonoscopy: accelerating microbiome stabilization by Clostridium butyricum.
Chen Z; Yu L; Liu J; Kong J; Deng X; Guo X; Shan J; Zhou D; Li W; Lin Y; Huang W; Zeng W; Shi X; Bai Y; Fan H
J Transl Med; 2024 Mar; 22(1):222. PubMed ID: 38429821
[TBL] [Abstract][Full Text] [Related]
10. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.
McMurdie PJ; Stoeva MK; Justice N; Nemchek M; Sieber CMK; Tyagi S; Gines J; Skennerton CT; Souza M; Kolterman O; Eid J
BMC Microbiol; 2022 Jan; 22(1):19. PubMed ID: 34996347
[TBL] [Abstract][Full Text] [Related]
11. Dietary Clostridium butyricum Induces a Phased Shift in Fecal Microbiota Structure and Increases the Acetic Acid-Producing Bacteria in a Weaned Piglet Model.
Zhang J; Chen X; Liu P; Zhao J; Sun J; Guan W; Johnston LJ; Levesque CL; Fan P; He T; Zhang G; Ma X
J Agric Food Chem; 2018 May; 66(20):5157-5166. PubMed ID: 29683328
[TBL] [Abstract][Full Text] [Related]
12. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease.
Wang F; Qian F; Zhang Q; Zhao J; Cen J; Zhang J; Zhou J; Luo M; Jia C; Rong X; Chu M
Front Immunol; 2023; 14():1124118. PubMed ID: 37398673
[TBL] [Abstract][Full Text] [Related]
13. Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation.
Zhou D; Pan Q; Liu XL; Yang RX; Chen YW; Liu C; Fan JG
J Gastroenterol Hepatol; 2017 Sep; 32(9):1640-1648. PubMed ID: 28109017
[TBL] [Abstract][Full Text] [Related]
14.
Luo X; Han Z; Kong Q; Wang Y; Mou H; Duan X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902386
[TBL] [Abstract][Full Text] [Related]
15. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.
Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L
J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503
[TBL] [Abstract][Full Text] [Related]
16. Butyrate-producing human gut symbiont,
Stoeva MK; Garcia-So J; Justice N; Myers J; Tyagi S; Nemchek M; McMurdie PJ; Kolterman O; Eid J
Gut Microbes; 2021; 13(1):1-28. PubMed ID: 33874858
[No Abstract] [Full Text] [Related]
17. Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway.
Wu Y; He F; Zhang C; Zhang Q; Su X; Zhu X; Liu A; Shi W; Lin W; Jin Z; Yang H; Lin J
J Nanobiotechnology; 2021 Jun; 19(1):170. PubMed ID: 34092246
[TBL] [Abstract][Full Text] [Related]
18. Effects of Clostridium butyricum and Enterococcus faecalis on growth performance, immune function, intestinal morphology, volatile fatty acids, and intestinal flora in a piglet model.
Wang K; Cao G; Zhang H; Li Q; Yang C
Food Funct; 2019 Dec; 10(12):7844-7854. PubMed ID: 31793606
[TBL] [Abstract][Full Text] [Related]
19. Combined Use of
Long M; Yang S; Li P; Song X; Pan J; He J; Zhang Y; Wu R
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29937527
[TBL] [Abstract][Full Text] [Related]
20. Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate.
Sun J; Xu J; Yang B; Chen K; Kong Y; Fang N; Gong T; Wang F; Ling Z; Liu J
Mol Nutr Food Res; 2020 Jan; 64(2):e1900636. PubMed ID: 31835282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
